Cargando…
PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430243/ http://dx.doi.org/10.1097/01.HS9.0000974116.36901.ed |
_version_ | 1785090914700492800 |
---|---|
author | Sofía, Álvarez-Galeano Salazar-Hidalgo, Milton Benavente, Celina López-Lorenzo, José Luis Anguita, Eduardo |
author_facet | Sofía, Álvarez-Galeano Salazar-Hidalgo, Milton Benavente, Celina López-Lorenzo, José Luis Anguita, Eduardo |
author_sort | Sofía, Álvarez-Galeano |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104302432023-08-17 PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION Sofía, Álvarez-Galeano Salazar-Hidalgo, Milton Benavente, Celina López-Lorenzo, José Luis Anguita, Eduardo Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430243/ http://dx.doi.org/10.1097/01.HS9.0000974116.36901.ed Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Sofía, Álvarez-Galeano Salazar-Hidalgo, Milton Benavente, Celina López-Lorenzo, José Luis Anguita, Eduardo PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION |
title | PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION |
title_full | PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION |
title_fullStr | PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION |
title_full_unstemmed | PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION |
title_short | PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION |
title_sort | pb1817: the addition of zalcitabine to acute myeloid leukemia treatment may improve azacitidine and venetoclax combination |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430243/ http://dx.doi.org/10.1097/01.HS9.0000974116.36901.ed |
work_keys_str_mv | AT sofiaalvarezgaleano pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination AT salazarhidalgomilton pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination AT benaventecelina pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination AT lopezlorenzojoseluis pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination AT anguitaeduardo pb1817theadditionofzalcitabinetoacutemyeloidleukemiatreatmentmayimproveazacitidineandvenetoclaxcombination |